2024 Pharma Report One-Pager: Trust vs. Reputation
Our latest one pager breaks down the differences between Trust and Reputation, and why Pharma companies need to measure them both.
Reputation Intelligence for the Pharmaceutical Industry
Build Trust in Every Care Journey.
Leverage data-driven insights to monitor, measure, and manage your reputation in the Pharmaceutical industry.
Balancing Innovation with Public Trust.
While innovation drives progress, public skepticism around drug pricing, transparency, and ethics can erode trust. Negative perceptions not only damage stakeholder relationships but also impact market value. In this high-stakes environment, maintaining your brand's reputation is essential to long-term success.
Your Strategic Partner
RepTrak equips Pharma companies with the tools necessary to navigate complex reputational challenges. With continuous insights into public sentiment, media impact, and regulatory perceptions, RepTrak empowers teams to make data-driven decisions. Our team of experts partner with clients to manage risks, enhance trust, and stay ahead in an evolving industry.
Insights & Recommendations
Recommendations from experts who understand the nuances of the Pharma industry across global markets.
Proven Methodology
Scientifically validated approach, fine-tuned for Pharma, providing insights you can act on with confidence.
Historical Database
Leverage millions of global data points from over 20 years and learn from leaders who’ve transformed their reputation.
Built for Data-Driven Communication Teams
Insights and Recommendations from Industry Experts
Stakeholder Analysis
Gain insights into the perceptions and expectations of patients, regulators, healthcare professionals, and other key stakeholders.
Global & Local Pharma Insights
2024 Pharma Report
The 2024 Pharma Report offers a comprehensive view of the Pharmaceutical industry's reputation landscape, highlighting key trends and challenges across global markets. As public expectations continue to rise in the post-pandemic environment, Pharma companies are confronted with increased regulations, demands for quick innovations, and shaky relationships with critical stakeholders.
Fill out the form to learn more about what's driving the industry's reputation recovery — and where improvement is still needed.
Previous reports can be found here:
Fill out the form
Download the 2024 report here
Loading...
STAY UPDATED
See the latest reputation insights
2024 Pharma Report
This report breaks down the key Drivers of Pharma's reputation recovery, regional trust differences, and actionable strategies to boost your company's reputation in a changing market.
2024 Annual American Banker Study
From the RepTrak x American Banker 2024 annual reputation study, we’re presenting key data on stakeholder perceptions of the banking industry following the 2023 crisis.
Setting Smarter KPIs: The Power of Industry Benchmarks
In this blog, we explore how using industry benchmarks to set KPIs can arm your company with a strategy to stand out from the crowd.
Q2 2024 Data Dose: Reputation Power Plays
In this 5-point listicle, we provide concrete ways to boost your reputation strategy and increase favor with stakeholders.
Stand Out in a Crowd: Industry Comparison Dashboard
RepTrak's new Industry Comparison Dashboard puts the right industry data at your fingertips — so you know just how to position your company strategy amongst the competition.
Q2 2024 Data Dose One-Pager: Quality Perceptions
In this single-page blueprint, you'll learn what stakeholders think has the most influence on the quality of the products and services they purchase.
Q2 2024 Data Dose Quick Slides: Green Actions, Golden Reputation
Our latest set of quick slides breaks down how sustainable efforts shape stakeholder perception across key business areas.
Q2 2024 Data Dose Infographic: Public Perceptions
This infographic uncovers whose opinions matter most to your customers when forming opinions about your company.
Insights to Action: Advisory Services Quick Slides
In these quick slides, we break down how our Advisory team can help transform your reputation management strategy.
2024 Pharma Report One-Pager: Trust vs. Reputation
Our latest one pager breaks down the differences between Trust and Reputation, and why Pharma companies need to measure them both.
2024 Pharma Report
This report breaks down the key Drivers of Pharma's reputation recovery, regional trust differences, and actionable strategies to boost your company's reputation in a changing market.
2024 Annual American Banker Study
From the RepTrak x American Banker 2024 annual reputation study, we’re presenting key data on stakeholder perceptions of the banking industry following the 2023 crisis.
Setting Smarter KPIs: The Power of Industry Benchmarks
In this blog, we explore how using industry benchmarks to set KPIs can arm your company with a strategy to stand out from the crowd.
Q2 2024 Data Dose: Reputation Power Plays
In this 5-point listicle, we provide concrete ways to boost your reputation strategy and increase favor with stakeholders.
Stand Out in a Crowd: Industry Comparison Dashboard
RepTrak's new Industry Comparison Dashboard puts the right industry data at your fingertips — so you know just how to position your company strategy amongst the competition.
Q2 2024 Data Dose One-Pager: Quality Perceptions
In this single-page blueprint, you'll learn what stakeholders think has the most influence on the quality of the products and services they purchase.
Q2 2024 Data Dose Quick Slides: Green Actions, Golden Reputation
Our latest set of quick slides breaks down how sustainable efforts shape stakeholder perception across key business areas.
Q2 2024 Data Dose Infographic: Public Perceptions
This infographic uncovers whose opinions matter most to your customers when forming opinions about your company.
Insights to Action: Advisory Services Quick Slides
In these quick slides, we break down how our Advisory team can help transform your reputation management strategy.